RVMD
Common StockRevolution Medicines, Inc.
Healthcare
Reported Shares
10.6M
Position Mix
No options reported
Reported Value
$2.2B
Portfolio Weight
54.66%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$4.0B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
10.6M
Position Mix
No options reported
Reported Value
$2.2B
Portfolio Weight
54.66%
GMAB
Depositary ReceiptGENMAB A/S
Reported Shares
17.9M
Position Mix
No options reported
Reported Value
$638.6M
Portfolio Weight
16.00%
BLTE
Depositary ReceiptBELITE BIO, INC
Reported Shares
3.1M
Position Mix
No options reported
Reported Value
$526.0M
Portfolio Weight
13.18%
ABVX
Depositary ReceiptAbivax S.A.
Reported Shares
4M
Position Mix
No options reported
Reported Value
$398.2M
Portfolio Weight
9.98%
ROIV
Common StockRoivant Sciences Ltd.
Reported Shares
6.7M
Position Mix
No options reported
Reported Value
$246.7M
Portfolio Weight
6.18%